CD33 and acute myeloid leukemia: Furthermore, flow cytometry analysis demonstrated that the expression levels of AML-associated immunophenotypic markers (CD33, CD123, and CD11b) in bone marrow naïve cells were markedly downregulated 30 days post-treatment with IONPs+Ara-C.